{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:37:31Z","timestamp":1791862651310,"version":"4.3.4"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T00:00:00Z","timestamp":1664236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T00:00:00Z","timestamp":1664236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54 HD104461"],"award-info":[{"award-number":["U54 HD104461"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54 HD082008"],"award-info":[{"award-number":["U54 HD082008"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurodevelop Disord"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Fragile X syndrome (FXS) is the most common inherited form of neurodevelopmental disability. It is often characterized, especially in males, by intellectual disability, anxiety, repetitive behavior, social communication deficits, delayed language development, and abnormal sensory processing. Recently, we identified electroencephalographic (EEG) biomarkers that are conserved between the mouse model of FXS (<jats:italic>Fmr1 KO<\/jats:italic> mice) and humans with FXS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this report, we evaluate small molecule target engagement utilizing multielectrode array electrophysiology in the <jats:italic>Fmr1 KO<\/jats:italic> mouse and in humans with FXS. Neurophysiologic target engagement was evaluated using single doses of the GABA<jats:sub>B<\/jats:sub> selective agonist racemic baclofen (RBAC).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In <jats:italic>Fmr1<\/jats:italic> KO mice and in humans with FXS, baclofen use was associated with suppression of elevated gamma power and increase in low-frequency power at rest. In the <jats:italic>Fmr1<\/jats:italic> KO mice, a baclofen-associated improvement in auditory chirp synchronization was also noted.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Overall, we noted synchronized target engagement of RBAC on resting state electrophysiology, in particular the reduction of aberrant high frequency gamma activity, across species in FXS. This finding holds promise for translational medicine approaches to drug development for FXS, synchronizing treatment study across species using well-established EEG biological markers in this field.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>The human experiments are registered under NCT02998151.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s11689-022-09455-9","type":"journal-article","created":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T08:03:05Z","timestamp":1664265785000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Baclofen-associated neurophysiologic target engagement across species in fragile X syndrome"],"prefix":"10.1186","volume":"14","author":[{"given":"Carrie R.","family":"Jonak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest V.","family":"Pedapati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren M.","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha A.","family":"Assad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manbir S.","family":"Sandhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"DeStefano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Ethridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaleel A.","family":"Razak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Sweeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devin K.","family":"Binder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig A.","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,27]]},"reference":[{"key":"9455_CR1","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/00125817-200109000-00006","volume":"3","author":"DC Crawford","year":"2001","unstructured":"Crawford DC, Acu\u00f1a JM, Sherman SL. FMR1 and the fragile X syndrome: human genome epidemiology review. Genetics Med. 2001;3:359\u201371.","journal-title":"Genetics Med"},{"key":"9455_CR2","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1126\/science.252.5009.1179","volume":"252","author":"S Yu","year":"1991","unstructured":"Yu S, Pritchard M, Kremer E, Lynch M, Nancarrow J, Baker E, et al. Fragile X genotype characterized by an unstable region of DNA. Science. 1991;252:1179\u201381.","journal-title":"Science."},{"key":"9455_CR3","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.cell.2011.06.013","volume":"146","author":"C Darnell Jennifer","year":"2011","unstructured":"Darnell Jennifer C, Van Driesche SJ, Zhang C, Hung Ka Ying S, Mele A, Fraser Claire E, et al. FMRP stalls ribosomal translocation on mrnas linked to synaptic function and autism. Cell. 2011;146:247\u201361.","journal-title":"Cell."},{"key":"9455_CR4","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/(SICI)1098-2779(1997)3:4<313::AID-MRDD6>3.0.CO;2-O","volume":"3","author":"L Abbeduto","year":"1997","unstructured":"Abbeduto L, Hagerman RJ. Language and communication in fragile X syndrome. Ment Retard Dev Disabil Res Rev. 1997;3:313\u201322.","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"9455_CR5","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1111\/j.1469-8749.2002.tb00277.x","volume":"44","author":"E Berry-Kravis","year":"2002","unstructured":"Berry-Kravis E. Epilepsy in fragile X syndrome. Dev Med Child Neurol. 2002;44:724\u20138.","journal-title":"Dev Med Child Neurol"},{"key":"9455_CR6","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1542\/peds.2008-0317","volume":"123","author":"RJ Hagerman","year":"2009","unstructured":"Hagerman RJ, Berry-Kravis E, Kaufmann WE, Ono MY, Tartaglia N, Lachiewicz A, et al. Advances in the treatment of fragile X syndrome. Pediatrics. 2009;123:378\u201390.","journal-title":"Pediatrics."},{"key":"9455_CR7","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/(SICI)1096-8628(19990402)83:4<268::AID-AJMG7>3.0.CO;2-K","volume":"83","author":"LJ Miller","year":"1999","unstructured":"Miller LJ, McIntosh DN, McGrath J, Shyu V, Lampe M, Taylor AK, et al. Electrodermal responses to sensory stimuli in individuals with fragile X syndrome: a preliminary report. Am J Med Genet. 1999;83:268\u201379.","journal-title":"Am J Med Genet"},{"key":"9455_CR8","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1111\/j.1528-1157.1999.tb00824.x","volume":"40","author":"SA Musumeci","year":"1999","unstructured":"Musumeci SA, Hagerman RJ, Ferri R, Bosco P, Bernardina BD, Tassinari CA, et al. Epilepsy and EEG findings in males with fragile X syndrome. Epilepsia. 1999;40:1092\u20139.","journal-title":"Epilepsia."},{"key":"9455_CR9","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1177\/10538151010240030601","volume":"24","author":"JE Roberts","year":"2001","unstructured":"Roberts JE, Hatton DD, Bailey DB. Development and behavior of male toddlers with fragile X syndrome. J Early Interv. 2001;24:207\u201323.","journal-title":"J Early Interv"},{"key":"9455_CR10","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1053\/seiz.2000.0492","volume":"10","author":"M Sabaratnam","year":"2001","unstructured":"Sabaratnam M, Vroegop PG, Gangadharan SK. Epilepsy and EEG findings in 18 males with fragile X syndrome. Seizure. 2001;10:60\u20133.","journal-title":"Seizure."},{"issue":"Pt B","key":"9455_CR11","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.neubiorev.2016.05.029","volume":"76","author":"D Sinclair","year":"2017","unstructured":"Sinclair D, Oranje B, Razak KA, Siegel SJ, Schmid S. Sensory processing in autism spectrum disorders and Fragile X syndrome-From the clinic to animal models. Neurosci Biobehav Rev. 2017;76(Pt B):235\u201353.","journal-title":"Neurosci Biobehav Rev"},{"key":"9455_CR12","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.ridd.2009.10.013","volume":"31","author":"MJW Van der Molen","year":"2010","unstructured":"Van der Molen MJW, Huizinga M, Huizenga HM, Ridderinkhof KR, Van der Molen MW, Hamel BJC, et al. Profiling Fragile X Syndrome in males: strengths and weaknesses in cognitive abilities. Res Dev Disabil. 2010;31:426\u201339.","journal-title":"Res Dev Disabil"},{"key":"9455_CR13","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/ajmg.1320380267","volume":"38","author":"KE Wisniewski","year":"1991","unstructured":"Wisniewski KE, Segan SM, Miezejeski CM, Sersen EA, Rudelli RD. The fra(X) syndrome: Neurological, electrophysiological, and neuropathological abnormalities. Am J Med Genet. 1991;38:476\u201380.","journal-title":"Am J Med Genet"},{"issue":"1","key":"9455_CR14","first-page":"fcz042","volume":"2","author":"LM Schmitt","year":"2020","unstructured":"Schmitt LM, Wang J, Pedapati EV, Thurman AJ, Abbeduto L, Erickson CA, et al. A neurophysiological model of speech production deficits in fragile X syndrome. Brain. Communications. 2020;2(1):fcz042.","journal-title":"Communications."},{"key":"9455_CR15","doi-asserted-by":"crossref","unstructured":"Erickson CA, Kaufmann WE, Budimirovic DB, Lachiewicz A, Haas-Givler B, Miller RM, et al. Best Practices in Fragile X Syndrome Treatment Development. Brain Sci. 2018;8(12).","DOI":"10.3390\/brainsci8120224"},{"issue":"3","key":"9455_CR16","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1023\/A:1022606200636","volume":"15","author":"M Castr\u00e9n","year":"2003","unstructured":"Castr\u00e9n M, Paakkonen A, Tarkka IM, Ryynanen M, Partanen J. Augmentation of auditory N1 in children with fragile X syndrome. Brain Topogr. 2003;15(3):165\u201371.","journal-title":"Brain Topogr"},{"issue":"10","key":"9455_CR17","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1177\/0269881113494105","volume":"27","author":"A Schneider","year":"2013","unstructured":"Schneider A, Leigh MJ, Adams P, Nanakul R, Chechi T, Olichney J, et al. Electrocortical changes associated with minocycline treatment in fragile X syndrome. J Psychopharmacol. 2013;27(10):956\u201363.","journal-title":"J Psychopharmacol"},{"key":"9455_CR18","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3389\/fnint.2019.00060","volume":"13","author":"LE Ethridge","year":"2019","unstructured":"Ethridge LE, De Stefano LA, Schmitt LM, Woodruff NE, Brown KL, Tran M, et al. Auditory EEG Biomarkers in Fragile X Syndrome: Clinical Relevance. Front Integr Neurosci. 2019;13:60.","journal-title":"Front Integr Neurosci"},{"key":"9455_CR19","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/nrd.2017.221","volume":"17","author":"EM Berry-Kravis","year":"2018","unstructured":"Berry-Kravis EM, Lindemann L, J\u00f8nch AE, Apostol G, Bear MF, Carpenter RL, et al. Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome. Nat Rev Drug Discov. 2018;17:280\u201399.","journal-title":"Nat Rev Drug Discov"},{"key":"9455_CR20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3389\/fnint.2019.00045","volume":"13","author":"JB Ewen","year":"2019","unstructured":"Ewen JB, Sweeney JA, Potter WZ. Conceptual, regulatory and strategic imperatives in the early days of EEG-based biomarker validation for neurodevelopmental disabilities. Front Integr Neurosci. 2019;13:45.","journal-title":"Front Integr Neurosci"},{"key":"9455_CR21","doi-asserted-by":"crossref","unstructured":"Sahin M, Jones SR, Sweeney JA, Berry-Kravis E, Connors BW, Ewen JB, et al. Discovering translational biomarkers in neurodevelopmental disorders. Nat Rev Drug Discov. 2018.","DOI":"10.1038\/d41573-018-00010-7"},{"key":"9455_CR22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3389\/fnint.2018.00053","volume":"12","author":"CR Jonak","year":"2018","unstructured":"Jonak CR, Lovelace JW, Ethell IM, Razak KA, Binder DK. Reusable multielectrode array technique for electroencephalography in awake freely moving mice. Front Integr Neurosci. 2018;12:53.","journal-title":"Front Integr Neurosci"},{"key":"9455_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.104794","volume":"138","author":"CR Jonak","year":"2020","unstructured":"Jonak CR, Lovelace JW, Ethell IM, Razak KA, Binder DK. Multielectrode array analysis of EEG biomarkers in a mouse model of Fragile X Syndrome. Neurobiol Dis. 2020;138:104794.","journal-title":"Neurobiol Dis"},{"key":"9455_CR24","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13229-017-0140-1","volume":"8","author":"LE Ethridge","year":"2017","unstructured":"Ethridge LE, White SP, Mosconi MW, Wang J, Pedapati EV, Erickson CA, et al. Neural synchronization deficits linked to cortical hyper-excitability and auditory hypersensitivity in fragile X syndrome. Mol Autism. 2017;8:22.","journal-title":"Mol Autism"},{"key":"9455_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s11689-017-9191-z","volume":"9","author":"J Wang","year":"2017","unstructured":"Wang J, Ethridge LE, Mosconi MW, White SP, Binder DK, Pedapati EV, et al. A resting EEG study of neocortical hyperexcitability and altered functional connectivity in fragile X syndrome. J Neurodev Disord. 2017;9:11.","journal-title":"J Neurodev Disord"},{"key":"9455_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2016.48","volume":"6","author":"LE Ethridge","year":"2016","unstructured":"Ethridge LE, White SP, Mosconi MW, Wang J, Byerly MJ, Sweeney JA. Reduced habituation of auditory evoked potentials indicate cortical hyper-excitability in Fragile X Syndrome. Transl Psychiatry. 2016;6:e787.","journal-title":"Transl Psychiatry"},{"key":"9455_CR27","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.neuroscience.2018.11.047","volume":"398","author":"TH Wen","year":"2019","unstructured":"Wen TH, Lovelace JW, Ethell IM, Binder DK, Razak KA. Developmental Changes in EEG Phenotypes in a Mouse Model of Fragile X Syndrome. Neuroscience. 2019;398:126\u201343.","journal-title":"Neuroscience."},{"key":"9455_CR28","doi-asserted-by":"publisher","first-page":"175909141880109","DOI":"10.1177\/1759091418801092","volume":"10","author":"M Rais","year":"2018","unstructured":"Rais M, Binder DK, Razak KA, Ethell IM. Sensory Processing Phenotypes in Fragile X Syndrome. ASN Neuro. 2018;10:1759091418801092.","journal-title":"ASN Neuro"},{"key":"9455_CR29","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.nbd.2018.03.012","volume":"115","author":"JW Lovelace","year":"2018","unstructured":"Lovelace JW, Ethell IM, Binder DK, Razak KA. Translation-relevant EEG phenotypes in a mouse model of Fragile X Syndrome. Neurobiol Dis. 2018;115:39\u201348.","journal-title":"Neurobiol Dis"},{"issue":"2","key":"9455_CR30","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.nbd.2005.07.017","volume":"21","author":"I Gantois","year":"2006","unstructured":"Gantois I, Vandesompele J, Speleman F, Reyniers E, D'Hooge R, Severijnen LA, et al. Expression profiling suggests underexpression of the GABA(A) receptor subunit delta in the fragile X knockout mouse model. Neurobiol Dis. 2006;21(2):346\u201357.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"9455_CR31","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.bbr.2012.01.031","volume":"229","author":"I Heulens","year":"2012","unstructured":"Heulens I, D'Hulst C, Van Dam D, De Deyn PP, Kooy RF. Pharmacological treatment of fragile X syndrome with GABAergic drugs in a knockout mouse model. Behav Brain Res. 2012;229(1):244\u20139.","journal-title":"Behav Brain Res"},{"issue":"1","key":"9455_CR32","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1124\/mol.109.056127","volume":"76","author":"LK Pacey","year":"2009","unstructured":"Pacey LK, Heximer SP, Hampson DR. Increased GABA(B) receptor-mediated signaling reduces the susceptibility of fragile X knockout mice to audiogenic seizures. Mol Pharmacol. 2009;76(1):18\u201324.","journal-title":"Mol Pharmacol"},{"issue":"152","key":"9455_CR33","doi-asserted-by":"publisher","first-page":"152ra27","DOI":"10.1126\/scitranslmed.3004214","volume":"4","author":"EM Berry-Kravis","year":"2012","unstructured":"Berry-Kravis EM, Hessl D, Rathmell B, Zarevics P, Cherubini M, Walton-Bowen K, et al. Effects of STX209 (Arbaclofen) on neurobehavioral function in children and adults with fragile X syndrome: a randomized, controlled, Phase 2 Trial. Sci Transl Med. 2012;4(152):152ra27.","journal-title":"Sci Transl Med"},{"issue":"152","key":"9455_CR34","doi-asserted-by":"publisher","first-page":"152ra28","DOI":"10.1126\/scitranslmed.3004218","volume":"4","author":"C Henderson","year":"2012","unstructured":"Henderson C, Wijetunge L, Kinoshita MN, Shumway M, Hammond RS, Postma FR, et al. Reversal of disease-related pathologies in the fragile X mouse model by selective activation of GABAB receptors with arbaclofen. Sci Transl Med. 2012;4(152):152ra28.","journal-title":"Sci Transl Med"},{"issue":"16","key":"9455_CR35","doi-asserted-by":"publisher","first-page":"6621","DOI":"10.1074\/jbc.M116.772541","volume":"292","author":"JY Kang","year":"2017","unstructured":"Kang JY, Chadchankar J, Vien TN, Mighdoll MI, Hyde TM, Mather RJ, et al. Deficits in the activity of presynaptic gamma-aminobutyric acid type B receptors contribute to altered neuronal excitability in fragile X syndrome. J Biol Chem. 2017;292(16):6621\u201332.","journal-title":"J Biol Chem"},{"key":"9455_CR36","doi-asserted-by":"crossref","unstructured":"Sinclair D, Featherstone R, Naschek M, Nam J, Du A, Wright S, et al. GABA-B agonist baclofen normalizes auditory-evoked neural oscillations and behavioral deficits in the Fmr1 knockout mouse model of fragile X syndrome. Eneuro. 2017;4 ENEURO.0380-16.2017.","DOI":"10.1523\/ENEURO.0380-16.2017"},{"key":"9455_CR37","doi-asserted-by":"crossref","unstructured":"Bakker CE, al. e, Verheij C, Willemsen R, Helm Rvd, Oerlemans F, et al. Fmr1 knockout mice: a model to study fragile X mental retardation. The Dutch-Belgian Fragile X Consortium. Cell. 1994;78(1):23-33.","DOI":"10.1016\/0092-8674(94)90569-X"},{"issue":"2","key":"9455_CR38","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","volume":"7","author":"AB Nair","year":"2016","unstructured":"Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 2016;7(2):27\u201331.","journal-title":"J Basic Clin Pharm"},{"issue":"2","key":"9455_CR39","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1007\/s13311-021-01042-5","volume":"18","author":"CR Jonak","year":"2021","unstructured":"Jonak CR, Sandhu MS, Assad SA, Barbosa JA, Makhija M, Binder DK. Correction to: the PDE10A inhibitor TAK-063 reverses sound-evoked EEG abnormalities in a mouse model of fragile X syndrome. Neurotherapeutics. 2021;18(2):1427.","journal-title":"Neurotherapeutics."},{"issue":"2","key":"9455_CR40","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s13311-021-01005-w","volume":"18","author":"CR Jonak","year":"2021","unstructured":"Jonak CR, Sandhu MS, Assad SA, Barbosa JA, Makhija M, Binder DK. The PDE10A Inhibitor TAK-063 reverses sound-evoked EEG abnormalities in a mouse model of fragile X syndrome. Neurotherapeutics. 2021;18(2):1175\u201387.","journal-title":"Neurotherapeutics."},{"key":"9455_CR41","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.neuroimage.2006.01.021","volume":"31","author":"RS Desikan","year":"2006","unstructured":"Desikan RS, et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. NeuroImage. 2006;31:968\u201380.","journal-title":"NeuroImage"},{"key":"9455_CR42","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.clinph.2003.10.021","volume":"115","author":"J Artieda","year":"2004","unstructured":"Artieda J, Valencia M, Alegre M, Olaziregi O, Urrestarazu E, Iriarte J. Potentials evoked by chirp-modulated tones: a new technique to evaluate oscillatory activity in the auditory pathway. Clin Neurophysiol. 2004;115:699\u2013709.","journal-title":"Clin Neurophysiol"},{"key":"9455_CR43","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.expneurol.2007.10.017","volume":"210","author":"M P\u00e9rez-Alc\u00e1zar","year":"2008","unstructured":"P\u00e9rez-Alc\u00e1zar M, Nicol\u00e1s MJJ, Valencia M, Alegre M, Iriarte J, Artieda J. Chirp-evoked potentials in the awake and anesthetized rat. A procedure to assess changes in cortical oscillatory activity. Exp Neurol. 2008;210:144\u201353.","journal-title":"Exp Neurol"},{"key":"9455_CR44","doi-asserted-by":"publisher","first-page":"3581","DOI":"10.1121\/1.1798354","volume":"116","author":"DW Purcell","year":"2004","unstructured":"Purcell DW, John SM, Schneider BA, Picton TW. Human temporal auditory acuity as assessed by envelope following responses. J Acoustical Soc Am. 2004;116:3581\u201393.","journal-title":"J Acoustical Soc Am"},{"key":"9455_CR45","doi-asserted-by":"publisher","first-page":"4240","DOI":"10.1523\/JNEUROSCI.16-13-04240.1996","volume":"16","author":"C Tallon-Baudry","year":"1996","unstructured":"Tallon-Baudry C, Bertrand O, Delpuech C, Pernier J. Stimulus specificity of phase-locked and non-phase-locked 40 Hz visual responses in human. J Neurosci. 1996;16:4240\u20139.","journal-title":"J Neurosci"},{"key":"9455_CR46","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.nbd.2019.01.002","volume":"124","author":"S Goswami","year":"2019","unstructured":"Goswami S, Cavalier S, Sridhar V, Huber KM, Gibson JR. Local cortical circuit correlates of altered EEG in the mouse model of Fragile X syndrome. Neurobiol Dis. 2019;124:563\u201372.","journal-title":"Neurobiol Dis"},{"key":"9455_CR47","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.neuron.2018.12.026","volume":"101","author":"MW Antoine","year":"2019","unstructured":"Antoine MW, Langberg T, Schnepel P, Feldman DE. Increased Excitation-Inhibition Ratio Stabilizes Synapse and Circuit Excitability in Four Autism Mouse Models. Neuron. 2019;101:648\u2013661 e644.","journal-title":"Neuron"},{"key":"9455_CR48","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.conb.2018.07.009","volume":"52","author":"AJ Mably","year":"2018","unstructured":"Mably AJ, Colgin LL. Gamma oscillations in cognitive disorders. Curr Opin Neurobiol. 2018;52:182\u20137.","journal-title":"Curr Opin Neurobiol"},{"key":"9455_CR49","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.neuron.2015.09.034","volume":"88","author":"P Fries","year":"2015","unstructured":"Fries P. Rhythms for Cognition: Communication through Coherence. Neuron. 2015;88:220\u201335.","journal-title":"Neuron"},{"key":"9455_CR50","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.tics.2005.08.011","volume":"9","author":"P Fries","year":"2005","unstructured":"Fries P. A mechanism for cognitive dynamics: neuronal communication through neuronal coherence. Trends Cogn Sci. 2005;9:474\u201380.","journal-title":"Trends Cogn Sci"},{"key":"9455_CR51","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1523\/JNEUROSCI.2057-12.2013","volume":"33","author":"JF Burke","year":"2013","unstructured":"Burke JF, et al. Synchronous and asynchronous theta and gamma activity during episodic memory formation. J Neurosci. 2013;33:292\u2013304.","journal-title":"J Neurosci"},{"key":"9455_CR52","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1162\/neco.2006.18.5.1066","volume":"18","author":"N Brunel","year":"2006","unstructured":"Brunel N, Hansel D. How noise affects the synchronization properties of recurrent networks of inhibitory neurons. Neural Comput. 2006;18:1066\u2013110.","journal-title":"Neural Comput"},{"key":"9455_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1002176","volume":"7","author":"D Battaglia","year":"2011","unstructured":"Battaglia D, Hansel D. Synchronous chaos and broad band gamma rhythm in a minimal multi-layer model of primary visual cortex. PLoS Comput Biol. 2011;7:e1002176.","journal-title":"PLoS Comput Biol"},{"key":"9455_CR54","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1523\/JNEUROSCI.2250-20.2021","volume":"41","author":"N Guyon","year":"2021","unstructured":"Guyon N, et al. Network Asynchrony Underlying Increased Broadband Gamma Power. J Neurosci. 2021;41:2944\u201363.","journal-title":"J Neurosci"},{"key":"9455_CR55","doi-asserted-by":"crossref","unstructured":"Pedapati EV, Schmitt LM, Ethridge LE, Miyakoshi M, Sweeney JA, Liu R, et al. Neocortical localization and thalamocortical modulation of neuronal hyperexcitability contribute to Fragile X Syndrome. Nat Commun Biol 2022.25","DOI":"10.1101\/2021.05.12.21256925"},{"issue":"Pt 2","key":"9455_CR56","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1113\/jphysiol.1996.sp021397","volume":"493","author":"RD Traub","year":"1996","unstructured":"Traub RD, Whittington MA, Colling SB, Buzsaki G, Jefferys JG. Analysis of gamma rhythms in the rat hippocampus in vitro and in vivo. J Physiol. 1996;493(Pt 2):471\u201384.","journal-title":"J Physiol"},{"issue":"1","key":"9455_CR57","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nrn2044","volume":"8","author":"M Bartos","year":"2007","unstructured":"Bartos M, Vida I, Jonas P. Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks. Nat Rev Neurosci. 2007;8(1):45\u201356.","journal-title":"Nat Rev Neurosci"},{"issue":"7247","key":"9455_CR58","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/nature07991","volume":"459","author":"VS Sohal","year":"2009","unstructured":"Sohal VS, Zhang F, Yizhar O, Deisseroth K. Parvalbumin neurons and gamma rhythms enhance cortical circuit performance. Nature. 2009;459(7247):698\u2013702.","journal-title":"Nature."},{"issue":"7","key":"9455_CR59","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.1038\/s41380-020-0840-3","volume":"26","author":"JM McNally","year":"2021","unstructured":"McNally JM, Aguilar DD, Katsuki F, Radzik LK, Schiffino FL, Uygun DS, et al. Optogenetic manipulation of an ascending arousal system tunes cortical broadband gamma power and reveals functional deficits relevant to schizophrenia. Mol Psychiatry. 2021;26(7):3461\u201375.","journal-title":"Mol Psychiatry"},{"issue":"42","key":"9455_CR60","doi-asserted-by":"publisher","first-page":"14194","DOI":"10.1523\/JNEUROSCI.3145-10.2010","volume":"30","author":"J Vienne","year":"2010","unstructured":"Vienne J, Bettler B, Franken P, Tafti M. Differential effects of GABAB receptor subtypes, {gamma}-hydroxybutyric Acid, and Baclofen on EEG activity and sleep regulation. J Neurosci. 2010;30(42):14194\u2013204.","journal-title":"J Neurosci"},{"issue":"8","key":"9455_CR61","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.5665\/sleep.1992","volume":"35","author":"J Vienne","year":"2012","unstructured":"Vienne J, Lecciso G, Constantinescu I, Schwartz S, Franken P, Heinzer R, et al. Differential effects of sodium oxybate and baclofen on EEG, sleep, neurobehavioral performance, and memory. Sleep. 2012;35(8):1071\u201383.","journal-title":"Sleep."},{"key":"9455_CR62","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jpsychires.2021.03.057","volume":"138","author":"EG Smith","year":"2021","unstructured":"Smith EG, Pedapati EV, Liu R, Schmitt LM, Dominick KC, Shaffer RC, et al. Sex differences in resting EEG power in Fragile X Syndrome. J Psychiatr Res. 2021;138:89\u201395.","journal-title":"J Psychiatr Res"}],"container-title":["Journal of Neurodevelopmental Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11689-022-09455-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11689-022-09455-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11689-022-09455-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T09:03:31Z","timestamp":1664269411000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneurodevdisorders.biomedcentral.com\/articles\/10.1186\/s11689-022-09455-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,27]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["9455"],"URL":"https:\/\/doi.org\/10.1186\/s11689-022-09455-9","relation":{},"ISSN":["1866-1947","1866-1955"],"issn-type":[{"value":"1866-1947","type":"print"},{"value":"1866-1955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,27]]},"assertion":[{"value":"15 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All human research described in this manuscript was reviewed and approved by the Cincinnati Children\u2019s Hospital Medical Center Institutional Review Board (IRB; IRB reference number 2015-8804). Informed consent was obtained from the guardian of all subjects enrolled in the human subjects research described in this manuscript.All animal research described in this manuscript was approved by the University of California Riverside Institutional Animal Care and Use Committee (IACUC).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"CAE and EVP are inventors on a patent(s) that focus on new treatment development in fragile X syndrome held by the Cincinnati Children\u2019s Research Foundation (CCRF) and licensed out at the discretion of CCRF. CAE is a current consultant to Impel, Stalicla, and Scioto Bioscience.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"52"}}